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Abstract
It is now commonplace to investigate tumour samples using whole-genome
sequencing, and some commonly performed tasks are the estimation of
cellularity (or sample purity), the genome-wide profiling of copy numbers, and
the assessment of sub-clonal behaviours. Several tools are available to
undertake these tasks, but often give conflicting results – not least because
there is often genuine uncertainty due to a lack of model identifiability. 
Presented here is a tool, "Crambled", that allows for an intuitive visual
comparison of the conflicting solutions. Crambled is implemented as a Shiny
application within R, and is accompanied by example images from two use
cases (one tumour sample with matched normal sequencing, and one
standalone cell line example) as well as functions to generate the necessary
images from any sequencing data set. 
Through the use of Crambled, a user may gain insight into why each tool has
offered its given solution and combined with a knowledge of the disease being
studied can choose between the competing solutions in an informed manner.
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Introduction
The generation of whole-genome sequencing data to investigate 
tumour samples has become commonplace, thanks in particular to 
initiatives such as the International Cancer Genome Consortium 
(ICGC)1. Among the analyses being applied to the data generated 
are investigations of copy number changes2, structural variants3, 
and sub-clonality4. These analyses typically require the establish-
ment of segmented copy number profiles for the sample, which in 
turn rely on estimating the degree of contamination of normal tissue 
in a sample and the mean ploidy (equivalently the depth of coverage 
associated with a particular copy number state or the increase in 
depth associated with an increment in copy number).
Many tools have been developed that allow for the estimation of 
one or more of sample purity, copy number profile and clonality. 
These include e.g. ABSOLUTE (www.broadinstitute.org/cancer/
cga/absolute)5, ASCAT (heim.ifi.uio.no/bioinf/Projects/ASCAT)6, 
CloneHD (github.com/andrej-fischer/cloneHD)7, OncoSNP-SEQ 
(sites.google.com/site/oncosnpseq/)8 and QPure (sourceforge.
net/projects/qpure/)9 (for a more complete review see Yadav and 
De.10). There are real problems of model identifiability in perform-
ing this task, particularly when sub-clonal solutions are allowed, as 
any errors or discrepancies in the purity, segmentation or identifica-
tion of mean ploidy can often be explained as sub-clonal behaviour 
(many of the issues are discussed in Lonnstedt et al.11). Indeed, 
many tools acknowledge the inherent uncertainty in the calcula-
tions. As a consequence, applying two tools to a data set may return 
two conflicting solutions.
Contrasting this problem with another common analysis applied to 
whole-genome cancer sequencing data, that of identifying somatic 
single nucleotide variants and indels then there is one striking 
difference: SNV calls can be easily validated. This can be via a 
targeted experimental approach, or increasingly commonly through 
visual assessment using a tool such as the Integrative Genomics 
Viewer12.
Herein is presented the Crambled tool to enable the visual assess-
ment of the alternative purity/depth-of-sequencing solutions that 
can arise for a tumour sample. Through exploration of the solutions 
using Crambled one may achieve an appreciation of the reasons for 
each to have been offered. Coupled with knowledge of the tumour 
type, and the case history and pathology of the particular patient under 
examination, it may be possible to then select a preferred solution.
Methods
Implementation
Overview. The Crambled tool is implemented as a Shiny13 applica-
tion in R14. In essence it takes in a figure depicting the sequenc-
ing data (akin to a patchwork plot15 or grid plot11), constructs a 
second figure based on a solution for the cellularity/depth condi-
tions, and displays them in a superimposed manner. By allowing 
for a dynamic adjustment of the cellularity/depth solution being 
considered, Crambled enables an intuitive comparison of compet-
ing solutions and a tactile exploration of the solution space that pro-
vides insight into why different tools offer different solutions and 
informs the user in choosing between them.
The Crambled tool is divided into two sections as depicted in 
Figure 1, nominally a ‘client’ side and a ‘server’ side, to avoid having 
to upload across a network the large BAM files that contain the 
genome sequencing data.
Figure 1. A schematic of the operation of the Crambled tool. Tasks are divided between those on the ‘client’ side (that aim to reduce 
the size of the data that need to be transferred) and the main application on the ‘server’ side (where the cellularity/depth solutions can be 
investigated).
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Even when both ‘client’ and ‘server’ sides are run on the same 
machine, as is envisaged for a typical user, there are clear benefits 
to the division of labours. The initial data processing is an expensive 
operation and should only be performed once, with the output stored 
for potential repeated and spontaneous investigations in the future.
‘Server’-side tools. The Crambled application consists primarily of 
a dialogue box for selecting an image representing a sequencing 
experiment, two sliders for specifying cellularity and the depth of a 
single copy (that is the depth associated with a single copy present 
in all cells in a sample or, equivalently, half of the depth of cov-
erage in diploid regions), and a display that dynamically updates 
the selected image with superimposed predictions based on the 
chosen values.
The display figure is generated by first writing out the predictions 
to a temporary image before the two image files are combined. For 
two values, cellularity (C) and single-copy depth (D), the initial 
predictions for a region with n1 copies of one allele and n2 copies 
of the second are:














+ × + −
            
(2)
These values are depicted in Figure 2.
Figure 2. Deriving the predicted values used by Crambled. Top left: The basic predicted depths of sequencing and allele fractions that are 
expected for a number of copy number states. Top right: For six cases the uncertainty in the allele fraction that will be observed is illustrated. 
Bottom left: When the distribution folds at the 0.5 level, the expected value of the allele fraction is reduced. Bottom right: The predicted depths 
of sequencing and allele fractions that are used in the Crambled tool.
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For a locus that is heterozygous in the germline sample, the observed 
minor allele fraction is recorded. If the SNPs are phased, and one 
is considering a region in allelic balance, then it is possible to take 
all the allele fractions from one allele and gain a mean fraction of 
0.5. Without the phasing information, the minor allele will be taken 
at each locus and so the mean allele fraction recorded in the region 
will be below 0.5. Even in regions of strong allelic imbalance, it is 
possible that the observed allele fraction can exceed 0.5 when the 
true value does not, and so the mean allele fraction in those regions 
will also be biased.
Given the true minor allele fraction and depth, the observed fraction 
of the true minor allele has an estimable probability distribution. 
The mass of probability for allele fractions greater than 0.5 then 
‘folds’ below 0.5 to reflect the distribution of the observed frac-
tion of the observed minor allele, which is the value recorded. In 
this manner, the mean of the distribution is reduced. This effect is 
greater for small depths of sequencing due to the greater variance in 
observed allele fraction that comes from having a smaller denomi-
nator. The effect is greater also for allele fractions that are close to 
0.5 (Figure 2).
The final options available in the server interface allow the user to 
edit some of the metadata concerning the image loaded into Cram-
bled. Specifically, the user can depict a different range of depths as 
appropriate for their experimental data, and can specify the size of 
the image if this is different to the default.
‘Client’-side tools. It may be that the user will already have details 
of germline variants, and their depths and allelic fractions in the 
tumour sample, from which to create an image to load into Cram-
bled. Such data may be purposefully sought from tools such as GATK 
(www.broadinstitute.org/gatk/)16, SAMtools (www.htslib.org/)17, or 
parabam (parabam.readthedocs.org/). Alternatively, the information 
may be available as the side effect of running a somatic mutation 
caller. In the event that such data are not available, functions are 
supplied with Crambled to enable suitable data to be generated from 
BAM files.
The function CrambledScan() is accompanied by a file that lists 
(for Human Genome Issue 19) 177,299 sites that are highly likely 
to be heterozygous in a sample. This was generated from the 
“snp138Common” table for hg19 from the UCSC Table Browser18. 
Rsamtools19 is used to interrogate the BAM files at those locations. 
At a depth of coverage of about 40×, this typically returns approxi-
mately 80,000 heterozygous sites once quality filters have been put 
in place.
A running median is then applied to the depths and allele fractions at 
these sites to reduce noise. Note that this is not an attempt to charac-
terize the entire genome, but merely to capture the cellularity infor-
mation. Thus it does not matter if fine-grain copy number changes 
are lost in this smoothing. Ideally one would have as many germ-
line heterozygous loci as possible (typically 2,000,000 such loci for 
an individual), but extracting them comes at a computational cost. 
The approximately 80,000 loci used here will usually suffice for 
this limited task, and fewer may be feasible as seen in Figure 3.
The need for using a running average is also demonstrated in 
Figure 3. Note that as the number of heterozygous loci being used 
decreases, then a window of, e.g., 50 loci represents a much larger 
genomic region, making it more likely that the values being aver-
aged represent several distinct states and that the average will not 
represent a true state. Reducing that window will increase the noise 
in the picture and so a balance must be sought that reflects the com-
plexity of the genome being studied.
The plotting function (CrambledPlot) takes the output of this 
approach and produces a standard R plot, but with parameters set 
to values that the Crambled application will anticipate. Should it 
be necessary to change these, e.g. to increase the limits on the plot-
ting area because a sample has been sequenced to 500× depth of 
coverage, then the Crambled app needs to be informed via the 
metadata input options.
Operation
The tool and code presented here are built on top of R14 and Shiny13, 
and thus will run on a large number of operating systems. The 
dependencies within R are on the ‘Shiny’ package (obtainable from 
The Comprehensive R Archive Network [cran.r-project.org]) to run 
the application, and the ‘Rsamtools’ packages from Bioconductor20 
required for the code to prepare images for Crambled. Naturally, 
if the BAM files have been aligned against a genome other than 
human genome issue HG-19, then the list of suggested loci for 
investigation that accompanies the Crambled tool will not be rel-
evant and an alternative list must be generated. The user must create 
an image from the sequencing data of interest (either using the code 
provided, or independently in the style of the example images) and 
then load this into the Crambled application. The Crambled appli-
cation can be run on a local machine that has R and the R shiny 
package installed, or it can be run on a Linux machine running the 
Shiny Server software (www.rstudio.com/products/shiny/shiny-
server/). It has been extensively tested on a Ubuntu 12.04.5 machine 
running R version 3.2.1, Shiny 0.12.2 and Rsamtools 1.20.5. and 
an Apple computer running OS X version 10.9.5, R version 3.1.2, 
Shiny 0.11.1 and Rsamtools 1.18.3.
The code provided with Crambled for creating the images takes 
approximately 20 minutes to run (using a single processor on a rea-
sonable desktop machine) on a single 100GB cell line BAM file, or 
approximately an hour to run on two 150GB BAM files represent-
ing a tumour/normal pair.
Use cases
A tumour/normal pair
The first illustration of Crambled is an application to a previously 
published tumour/normal pair from an oesophageal adenocar-
cinoma (OAC) patient21. Two estimates of cellularity have been 
suggested in this case: 81% and 68%. While a small variation in 
estimates is natural, in this case the difference is too great to put 
down to the (in)stability of the estimate and it warrants investiga-
tion with the Crambled tool.
The first step is to generate the image to load into the Crambled 
Shiny application. Assuming that one has obtained the two BAM 
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Figure 3. The capabilities of a small number of loci to capture the grid-plot structure. Top left: A smoothed density plot of depth and 
B-allele fraction for sample SS6003302 (see Use Case 1) using 84,252 loci and no running average (equivalently a running average with a 
window length of 1). Top right: The same density plot with a running average (window size: 51 loci) first applied to the depth and minor allele 
fractions. Middle left, Middle right, Bottom left: The same density plots produced from samples of 50,000, 10,000 and 5,000 loci respectively. 
Bottom right: The same density plot produced from a sample of 1,000 loci and using a window of 11 loci for the running average.
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files (here called “SS6003301.bam” and “SS6003302.bam”), within 




This produces the file ‘SS6003022-shiny.png’ (available in the 
ExamplePlots folder at https://github.com/dralynch/crambled.git), 
that can be loaded into the Crambled application. The application 




to begin the tool. Uploading the figure, one can then test the two 
solutions as seen in Figure 4.
One can see that the solution with 81% tumour assumes that the 
sample is primarily diploid, with some regions of copy number 
loss and, crucially, some regions of data that lie off of the predicted 
grid and so must represent ‘sub-clonal’ states. By contrast, the 68% 
cellularity solution shows that all of the data lie on the predicted 
grid (i.e. there is little-to-no evidence of sub-clonality). However 
this solution suggests that the sample is broadly tetraploid.
Since OAC cases are often tetraploid, and this solution explains 
away all of the sub-clonality, the 68% cellularity solution seems 
to be the favourable one. While sub-clonal behaviour is also seen 
frequently in OAC, and the 81% solution is entirely valid, that the 
suggested sub-clonality conveniently only occurs at frequencies 
that can be explained by the tetraploid solution leads to a favouring 
of 68%.
A cell line
Cell lines present a different problem. Typically one would not be 
trying to estimate the cellularity of a cell line (which should be 
pure), but resolving the depth-of-sequencing/copy number can still 
be an issue, as can confirming that only a single population of cells 
is present.
Commonly, there will be no germline reference sample for a tumour 
cell line. Coupled with this, due to the (near-)perfect purity of a cell 
line, it is not possible to distinguish a germline homozygous site 
Figure 4. Resolving two competing solutions for a tumour/normal-tissue pair. Left: The solution at 81% cellularity fits the extremes of 
the data (the red contour) well, suggests a (hypo)diploid solution and leaves two states (blue regions in the density plot) unexplained by the 
clonal model (presumably representing sub-clonal behaviour). Right: The solution at 68% cellularity fits the extremes of the data equally well, 
and explains all of the main observed states, but suggests that the tumour is largely tetraploid.
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from a heterozygous site that has undergone loss-of-heterozygosity 
(LOH). Nor is it possible to distinguish a clonal somatic mutation 
from a germline-heterozygous site.
For the purposes of inferring cellularity, neither of these confusions 
matters except that in producing a patchwork- or grid- plot the sig-
nal from sites with no heterozygosity will drown out any observa-
tions from the (more informative) loci that have gained or retained 
heterozygosity. The purity of the cell line, and the consequent sepa-
rating of LOH-representing regions from other regions on the plot 
allows for separation of the two groups (with a simple threshold 
on allele fraction) and subsequent down-sampling of the LOH-like 
regions. Since this case requires different preparation, a separate 
command is provided for the creation of the plot.
This usage is illustrated using whole genome sequencing from 
the Genome Modelling System (github.com/genome/gms)22. 
Three lanes of whole genome sequencing data for the HCC1395 
breast cancer cell line (gerald_D1VCPACXX_1.bam, gerald_
D1VCPACXX_2.bam, and gerald_D1VCPACXX_3.bam) were 
downloaded (via github.com/genome/gms/wiki/HCC1395-WGS-
Exome-RNA-Seq-Data) and aligned to the EnsEMBL release 71 
assembly of the GRCh37 (hg19) human genome (apr2013.archive.
ensembl.org/index.html).
> source("crambledfunctions.R")
> CrambledScanCellline(normal="gerald_D1VCPACXX.   
      bam",title="HCC1395")
This produces the file ‘HCC1395-shiny.png’ (available in the 
ExamplePlots folder at https://github.com/dralynch/crambled.git). 
This image can be loaded into the Crambled application as per the 
previous use case. Therefore, within R one would type:
> library(shiny)
> runApp("crambled_app/")
The results can be seen in Figure 5. The cell line appears to be a 
single population of cells, with copy numbers mainly in the 2 to 
4 range (with some regions at a copy number of 1, and others at a 
copy number of 5 but with a four-to-one allele balance). Note that 
the thresholding of allele fractions may, at low depths, cause an 
artefactual data cloud to appear in the plot close to the threshold and 
suggestive of sub-clonality, but that this should be ignored.
Discussion
The code provided to produce the images to load into the Crambled 
application suffices for the intended purpose, but has shortcom-
ings with regard to other tasks. Firstly, it is prohibitively slow if 
one wishes to search for the complete set of informative loci in the 
genome, and the resolution that such a set brings to the problem is 
useful. One of the other tools mentioned in the introduction can be 
used if this is desired.
Secondly, there is no correction either for biases such as GC-related 
biases in the tumour sample, nor for regions of the normal sample 
that are polyploid, nor for artefactual mapping. Any of these would 
Figure 5. Illustrating the application to cell line data.
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reduce the noise in the figures (particularly that about the depth esti-
mate) and could potentially allow fewer loci, or a smaller window 
for the running average, to be used.
Finally, it should be noted that little effort is required to annotate 
the uploaded image more than is currently the case. Individual 
chromosomes could be picked out and highlighted using different 
colours. Alternatively, if one wanted to know whether e.g. TP53 had 
undergone LOH, it would be straightforward to mark the location of 
nearby SNPs and see where they lie in the plot.
Summary
Crambled is a tool that allows for interactive investigation of the 
multiple solutions that are possible when inferring the cellular-
ity (and related attributes) of a tumour sample that has undergone 
whole genome sequencing. Implemented as a Shiny application it 
can be used on most platforms and comes with example files and 
code to prepare such files from one’s own sequencing data.
Software availability
1. Software available from: https://dralynch.shinyapps.io/
crambled_app (limited usage server - the preference is for 
the user to download the Crambled application and run it 
locally)
2. Latest source code: https://github.com/dralynch/crambled.
git
3. Link to archived source code as at time of publication: http://
www.dx.doi.org/10.5281/zenodo.3414723
4. License: Lesser GNU Public License 2.0: https://www.gnu.
org/licenses/old-licenses/lgpl-2.0.html
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